Press Room

Share

U.S. House Set to Increase Medical Research Funding; Senate Should Increase Prevention Funding in Final FY 2022 Package

July 27, 2021

Washington, D.C.—Today the U.S. House of Representatives will begin debate on a package of funding bills for FY 2022, including funding for the National Institutes of Health (NIH) and the Centers for Disease Control and Prevention (CDC).

The bill includes $6.5 billion increase for medical research at NIH, including a $432 million increase for the National Cancer Institute, and $3.5 billion to create the Advanced Research Project Agency on Health (ARPA-H). Funding for critical cancer prevention programs, however, remains flat. This includes the National Breast and Cervical Cancer Early Detection Program (NBCCEDP), which provides free cancer screenings to under and uninsured patients.

A statement from Lisa Lacasse, president of the American Cancer Society Cancer Action Network (ACS CAN) follows:

“Throughout the pandemic cancer patients and survivors have reported significant delays in getting necessary cancer screenings, including those for breast and cervical cancer. The increased demand for screening services necessitates increased resources for programs like the NBCCEDP, which serves uninsured and underinsured patients and has provided more than 15.1 million screening exams to more than 5.8 million women since 1991.

“If we’re going to continue reducing the nation’s cancer burden, we need to prioritize prevention programs in addition to funding research. We urge the Senate to include increased funding for cancer prevention in their FY 2022 budget and for Congress to pass a final bill that increases resources for both research and prevention.”

More Press Releases AboutCancer Research Funding, Cancer Prevention, National

Media Contacts

Allison Miller
Director, Media Advocacy
Washington, D.C.
[email protected]
202-585-3241

Related Press Releases

March 21, 2024

Congress Considers FY24 Appropriations Bill That Prioritizes Cancer Research and Proven Cancer Screening Funding Amidst Difficult Budget Cycle

WASHINGTON, D.C.— March 21, 2024 — Today, Congress released a series of spending bills aimed to finalize FY2024 funding that includes a $300 million increase in funding for the National Health Institute (NIH) base budget, including a $120 million increase in discretionary funding for the National Cancer Institute (NCI), a modest $500,000 increase for the Centers for Disease Control and Prevention (CDC) cancer screening and prevention programs and maintains the current funding level for the Advanced Research Projects Agency for Health (ARPA-H) at $1.5 billion. At NIH, the bill also includes a first-time appropriation of $12.5 million in dedicated funding for the development of palliative care research at NIH and a new $6 million initiative for Improving Native American Cancer Outcomes. Within the Department of Defense (DoD), the bill includes a $110 million for the Prostate Cancer Research Program. 

Read More
March 24, 2023

New Jersey is taking a giant leap forward in the war against cancer. Here's how

The following originally appeared in the Asbury Park Press on March 24, 2023.

 

Read more
March 11, 2024

President’s FY25 Budget Prioritizes Funding for Cancer Research and Prevention

The American Cancer Society Cancer Action Network (ACS CAN) is pleased to see President Biden’s continued focus on and dedication to achieving the goal of the Cancer Moonshot to end cancer as we know it, for everyone.

Read more